HOME › DRUGS › ASFOTASE ALFA
ACTIVE SUBSTANCE / INN

ASFOTASE ALFA

Brand name(s): STRENSIQ, Strensiq
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Hypophosphatasia
BLA125513
ACTIVE SUBSTANCE
Asfotase Alfa
REGULATORS
FDA · EMA
SPONSORS / MAH
ALEXION PHARM, Alexion Europe SAS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
STRENSIQBLA125513ALEXION PHARMPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
StrensiqAlexion Europe SASAuthorised28/08/2015Hypophosphatasia

FULL INTELLIGENCE ON ASFOTASE ALFA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →